Circulating human cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for predicting the efficacy of IFNα treatment in chronic hepatitis B patients

The efficacy of interferon α (IFNα) therapy for chronic hepatitis B (CHB) patients is about 40% and often associates with adverse side-effects, thus identification of an easy accessible biomarker that can predict the outcome of IFNα treatment for individual CHB patients would be greatly helpful. Rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Pan, Yi, Wang, Nan, Zhou, Zhenxian, Liang, Hongwei, Pan, Chaoyun, Zhu, Dihan, Liu, Fenyong, Zhang, Chen-Yu, Zhang, Yujing, Zen, Ke
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785337/
https://ncbi.nlm.nih.gov/pubmed/26961899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep23007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados